Generally, Gal receptor 1 (GalR1) is involved in tumor suppression and exerts antiproliferative actions, whereas activation of GalR2 induces antiproliferative or proliferative effects in HN SCCs (168). The gene discussed is GALR2; the disease is neoplasm.